Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)

9 filings reported holding QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S as of Q2 2025.
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 0 shares of 9.35M outstanding shares and own 0% of the company stock.
Largest 9 shareholders include Apollon Wealth Management, LLC (0 shares), Raiffeisen Bank International AG (0 shares), JPMORGAN CHASE & CO (0 shares), RHUMBLINE ADVISERS (0 shares), Lido Advisors, LLC (0 shares), RAYMOND JAMES FINANCIAL INC (0 shares), MORGAN STANLEY (0 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), and UBS Group AG (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.